In an era when increasing demands are being made on the world’s healthcare services, generic and biosimilar medicines provide a major benefit to society by ensuring patient access to quality, safe and effective medicines while reducing the cost of pharmaceutical care.

The International Generic Pharmaceutical Alliance (IGPA) was founded in March 1997 as an international network of generic medicines associations. The name of the organization was changed in September 2015 to the International Generic and Biosimilar Medicines Association (IGBA) to reflect the evolving nature of the industry.



  • IGBA letter to FDA regarding their biologics naming proposals

    The International Generic and Biosimilar Medicines Association (IGBA), representing member associations from the U.S. (GPhA), Canada (CGPA), Japan (JGA), Jordan (JAPM), Europe (EGA), South Africa (NAPM), and Taiwan (TGPA), as well as associate member associations from Australia (GBMA), Brazil (ProGenericos) Read More
  • IGBA Welcomes ICH Reform and Openness For New Members

    JOHANNESBURG, SOUTH AFRICA (November 3, 2015).- The International Generic and Biosimilar Medicines Association (IGBA) welcomed the International Conference on Harmonisation (ICH) reform and the opening of the process to new members, including international industry organisations. The IGBA fully recognises the Read More
  • IGPA becomes IGBA and chairmanship shifts to South Africa

    TORONTO, CANADA (October 13, 2015).- Jim Keon, President of the Canadian Generic Pharmaceutical Association (CGPA) and Chair of the IGBA, announced at the IGBA Conference in Toronto that the International Generic and Biosimilar Medicines Association (IGBA) will register as an Read More
  • Global Pharmaceutical Associations Welcome MEDICRIME Convention, Landmark Tool to Curb Global Medicines Counterfeiting

    1 October 2015 – A unique international tool criminalizing the trade of counterfeit medicines, the Medicrime Convention, will enter into force on 1st January 2016, after 5 countries[1] out of its 24 signatories completed the ratification process. The Medicrime Convention, launched Read More
  • Statement by the International Generic Pharmaceutical Alliance (IGPA), Regarding the Trans-Pacific Partnership

    June 30, 2015 – The International Generic Pharmaceutical Alliance (IGPA) urges negotiators for the Trans-Pacific Partnership (TPP) not to abandon the needs of millions of the world’s citizens for access to affordable medicines.  Read More
  • 1
  • 2
  • 3
  • 4

18th Annual IGPA Conference

17th Annual IGPA Conference

16th Annual IGPA Conference

Contact Info


Rue d'Arlon, 50
B-1000 Brussels, Belgium

Telephone: +32 (0)2 736 84 11
Fax: +32 (0)2 736 74 38
E-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.